Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer

This cohort study compares the proportion of patients with urothelual cancer who initiated first-line chemotherapy and immune checkpoint inhibitors during the periods before and after avelumab approval.

Detalles Bibliográficos
Autores principales: Mamtani, Ronac, Zhang, Hanxi, Parikh, Ravi B., Patel, Khilna, Li, Haojie, Imai, Kentaro, Hubbard, Rebecca A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105303/
https://www.ncbi.nlm.nih.gov/pubmed/37058309
http://dx.doi.org/10.1001/jamanetworkopen.2023.8395
_version_ 1785026182355353600
author Mamtani, Ronac
Zhang, Hanxi
Parikh, Ravi B.
Patel, Khilna
Li, Haojie
Imai, Kentaro
Hubbard, Rebecca A.
author_facet Mamtani, Ronac
Zhang, Hanxi
Parikh, Ravi B.
Patel, Khilna
Li, Haojie
Imai, Kentaro
Hubbard, Rebecca A.
author_sort Mamtani, Ronac
collection PubMed
description This cohort study compares the proportion of patients with urothelual cancer who initiated first-line chemotherapy and immune checkpoint inhibitors during the periods before and after avelumab approval.
format Online
Article
Text
id pubmed-10105303
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-101053032023-04-16 Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer Mamtani, Ronac Zhang, Hanxi Parikh, Ravi B. Patel, Khilna Li, Haojie Imai, Kentaro Hubbard, Rebecca A. JAMA Netw Open Research Letter This cohort study compares the proportion of patients with urothelual cancer who initiated first-line chemotherapy and immune checkpoint inhibitors during the periods before and after avelumab approval. American Medical Association 2023-04-14 /pmc/articles/PMC10105303/ /pubmed/37058309 http://dx.doi.org/10.1001/jamanetworkopen.2023.8395 Text en Copyright 2023 Mamtani R et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License.
spellingShingle Research Letter
Mamtani, Ronac
Zhang, Hanxi
Parikh, Ravi B.
Patel, Khilna
Li, Haojie
Imai, Kentaro
Hubbard, Rebecca A.
Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
title Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
title_full Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
title_fullStr Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
title_full_unstemmed Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
title_short Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
title_sort uptake of maintenance immunotherapy and changes in upstream treatment selection among patients with urothelial cancer
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105303/
https://www.ncbi.nlm.nih.gov/pubmed/37058309
http://dx.doi.org/10.1001/jamanetworkopen.2023.8395
work_keys_str_mv AT mamtanironac uptakeofmaintenanceimmunotherapyandchangesinupstreamtreatmentselectionamongpatientswithurothelialcancer
AT zhanghanxi uptakeofmaintenanceimmunotherapyandchangesinupstreamtreatmentselectionamongpatientswithurothelialcancer
AT parikhravib uptakeofmaintenanceimmunotherapyandchangesinupstreamtreatmentselectionamongpatientswithurothelialcancer
AT patelkhilna uptakeofmaintenanceimmunotherapyandchangesinupstreamtreatmentselectionamongpatientswithurothelialcancer
AT lihaojie uptakeofmaintenanceimmunotherapyandchangesinupstreamtreatmentselectionamongpatientswithurothelialcancer
AT imaikentaro uptakeofmaintenanceimmunotherapyandchangesinupstreamtreatmentselectionamongpatientswithurothelialcancer
AT hubbardrebeccaa uptakeofmaintenanceimmunotherapyandchangesinupstreamtreatmentselectionamongpatientswithurothelialcancer

Ejemplares similares